349 related articles for article (PubMed ID: 21411759)
1. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.
Zou J; Sweeney CL; Chou BK; Choi U; Pan J; Wang H; Dowey SN; Cheng L; Malech HL
Blood; 2011 May; 117(21):5561-72. PubMed ID: 21411759
[TBL] [Abstract][Full Text] [Related]
2. An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.
Merling RK; Sweeney CL; Chu J; Bodansky A; Choi U; Priel DL; Kuhns DB; Wang H; Vasilevsky S; De Ravin SS; Winkler T; Dunbar CE; Zou J; Zarember KA; Gallin JI; Holland SM; Malech HL
Mol Ther; 2015 Jan; 23(1):147-57. PubMed ID: 25288370
[TBL] [Abstract][Full Text] [Related]
3. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells.
Dreyer AK; Hoffmann D; Lachmann N; Ackermann M; Steinemann D; Timm B; Siler U; Reichenbach J; Grez M; Moritz T; Schambach A; Cathomen T
Biomaterials; 2015 Nov; 69():191-200. PubMed ID: 26295532
[TBL] [Abstract][Full Text] [Related]
4. Targeted Repair of CYBB in X-CGD iPSCs Requires Retention of Intronic Sequences for Expression and Functional Correction.
Sweeney CL; Zou J; Choi U; Merling RK; Liu A; Bodansky A; Burkett S; Kim JW; De Ravin SS; Malech HL
Mol Ther; 2017 Feb; 25(2):321-330. PubMed ID: 28153086
[TBL] [Abstract][Full Text] [Related]
5. Third-generation, self-inactivating gp91(phox) lentivector corrects the oxidase defect in NOD/SCID mouse-repopulating peripheral blood-mobilized CD34+ cells from patients with X-linked chronic granulomatous disease.
Roesler J; Brenner S; Bukovsky AA; Whiting-Theobald N; Dull T; Kelly M; Civin CI; Malech HL
Blood; 2002 Dec; 100(13):4381-90. PubMed ID: 12393624
[TBL] [Abstract][Full Text] [Related]
6. Retroviral-mediated gene transfer of gp91phox into bone marrow cells rescues defect in host defense against Aspergillus fumigatus in murine X-linked chronic granulomatous disease.
Björgvinsdóttir H; Ding C; Pech N; Gifford MA; Li LL; Dinauer MC
Blood; 1997 Jan; 89(1):41-8. PubMed ID: 8978275
[TBL] [Abstract][Full Text] [Related]
7. Long-term correction of phagocyte NADPH oxidase activity by retroviral-mediated gene transfer in murine X-linked chronic granulomatous disease.
Dinauer MC; Li LL; Björgvinsdóttir H; Ding C; Pech N
Blood; 1999 Aug; 94(3):914-22. PubMed ID: 10419882
[TBL] [Abstract][Full Text] [Related]
8. Differential Transgene Silencing of Myeloid-Specific Promoters in the
Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.
Brault J; Vaganay G; Le Roy A; Lenormand JL; Cortes S; Stasia MJ
Int J Nanomedicine; 2017; 12():2161-2177. PubMed ID: 28356734
[TBL] [Abstract][Full Text] [Related]
10. Dual-regulated lentiviral vector for gene therapy of X-linked chronic granulomatosis.
Chiriaco M; Farinelli G; Capo V; Zonari E; Scaramuzza S; Di Matteo G; Sergi LS; Migliavacca M; Hernandez RJ; Bombelli F; Giorda E; Kajaste-Rudnitski A; Trono D; Grez M; Rossi P; Finocchi A; Naldini L; Gentner B; Aiuti A
Mol Ther; 2014 Aug; 22(8):1472-1483. PubMed ID: 24869932
[TBL] [Abstract][Full Text] [Related]
11. Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells.
Becker S; Wasser S; Hauses M; Hossle JP; Ott MG; Dinauer MC; Ganser A; Hoelzer D; Seger R; Grez M
Hum Gene Ther; 1998 Jul; 9(11):1561-70. PubMed ID: 9694155
[TBL] [Abstract][Full Text] [Related]
12. Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing.
Kaufmann KB; Brendel C; Suerth JD; Mueller-Kuller U; Chen-Wichmann L; Schwäble J; Pahujani S; Kunkel H; Schambach A; Baum C; Grez M
Mol Ther; 2013 Mar; 21(3):648-61. PubMed ID: 23207695
[TBL] [Abstract][Full Text] [Related]
13. High-level reconstitution of respiratory burst activity in a human X-linked chronic granulomatous disease (X-CGD) cell line and correction of murine X-CGD bone marrow cells by retroviral-mediated gene transfer of human gp91phox.
Ding C; Kume A; Björgvinsdóttir H; Hawley RG; Pech N; Dinauer MC
Blood; 1996 Sep; 88(5):1834-40. PubMed ID: 8781441
[TBL] [Abstract][Full Text] [Related]
14. Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapy.
Brendel C; Hänseler W; Wohlgensinger V; Bianchi M; Tokmak S; Chen-Wichmann L; Kuzmenko E; Cesarovic N; Nicholls F; Reichenbach J; Seger R; Grez M; Siler U
Hum Gene Ther Methods; 2013 Jun; 24(3):151-9. PubMed ID: 23489116
[TBL] [Abstract][Full Text] [Related]
15. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.
Kang EM; Choi U; Theobald N; Linton G; Long Priel DA; Kuhns D; Malech HL
Blood; 2010 Jan; 115(4):783-91. PubMed ID: 19965657
[TBL] [Abstract][Full Text] [Related]
16. Concentrated RD114-pseudotyped MFGS-gp91phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/beta -microglobulin-/- repopulating mobilized human peripheral blood CD34+ cells.
Brenner S; Whiting-Theobald NL; Linton GF; Holmes KL; Anderson-Cohen M; Kelly PF; Vanin EF; Pilon AM; Bodine DM; Horwitz ME; Malech HL
Blood; 2003 Oct; 102(8):2789-97. PubMed ID: 12829597
[TBL] [Abstract][Full Text] [Related]
17. Functional Restoration of gp91phox-Oxidase Activity by BAC Transgenesis and Gene Targeting in X-linked Chronic Granulomatous Disease iPSCs.
Laugsch M; Rostovskaya M; Velychko S; Richter C; Zimmer A; Klink B; Schröck E; Haase M; Neumann K; Thieme S; Roesler J; Brenner S; Anastassiadis K
Mol Ther; 2016 Apr; 24(4):812-22. PubMed ID: 26316390
[TBL] [Abstract][Full Text] [Related]
18. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
[TBL] [Abstract][Full Text] [Related]
19. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
[TBL] [Abstract][Full Text] [Related]
20. An in-frame triplet deletion within the gp91-phox gene in an adult X-linked chronic granulomatous disease patient with residual NADPH-oxidase activity.
Jendrossek V; Ritzel A; Neubauer B; Heyden S; Gahr M
Eur J Haematol; 1997 Feb; 58(2):78-85. PubMed ID: 9111587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
